دورية أكاديمية

The Evaluation of Outcomes after Thoracic Endovascular Aortic Repair for Type B Aortic Dissection in Mainland China.

التفاصيل البيبلوغرافية
العنوان: The Evaluation of Outcomes after Thoracic Endovascular Aortic Repair for Type B Aortic Dissection in Mainland China.
المؤلفون: Jia H; Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China; Department of Emergency Surgery, The People's Hospital of Peking University, Beijing, China., Yuan P; Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China., Wu S; National Clinical Research Centre of Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Yang R; Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China., Li HL; Division of Vascular Surgery, Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Guo W; Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China., Chen D; School of Life Science, Beijing Institute of Technology, Beijing, China. Electronic address: duanduan@bit.edu.cn., Xiong J; Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China. Electronic address: xiongjiang@301hospital.com.cn.
المصدر: Annals of vascular surgery [Ann Vasc Surg] 2024 Jul; Vol. 104, pp. 217-226. Date of Electronic Publication: 2024 Mar 18.
نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8703941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-5947 (Electronic) Linking ISSN: 08905096 NLM ISO Abbreviation: Ann Vasc Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: <2007->: Netherlands : Elsevier
Original Publication: Detroit : [Published by Expansion scientifique française for Annals of Vascular Surgery, Inc. and Association pour la promotion de la chirurgie vasculaire, Paris, c1986-
مواضيع طبية MeSH: Endovascular Procedures*/adverse effects , Endovascular Procedures*/mortality , Aortic Dissection*/surgery , Aortic Dissection*/mortality , Aortic Dissection*/diagnostic imaging , Hospital Mortality* , Aortic Aneurysm, Thoracic*/surgery , Aortic Aneurysm, Thoracic*/mortality , Aortic Aneurysm, Thoracic*/diagnostic imaging , Blood Vessel Prosthesis Implantation*/adverse effects , Blood Vessel Prosthesis Implantation*/mortality , Postoperative Complications*/mortality, Humans ; China ; Treatment Outcome ; Time Factors ; Risk Factors ; Risk Assessment ; Male ; Female ; Middle Aged ; Aged ; Endovascular Aneurysm Repair
مستخلص: Background: To assess the mortality and outcomes after thoracic endovascular aortic repair (TEVAR) in patients with type B aortic dissection (TBAD) in mainland China, and to compare these outcomes with data from Western countries, while analyzing the potential reasons for differences among different countries.
Methods: An extensive literature search spanning from January 1999 to October 2023 was conducted using PubMed, Cochrane Library, and Embase databases for studies on endovascular treatment for TBAD. This systematic review and meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Data extraction and analysis followed the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Primary outcomes were in-hospital mortality and mid-term (< 5 years) mortality.
Results: Based on 25 publications (3,080 patients), pooled estimate for in-hospital mortality was 2.2% (95% confidence interval, 1.6%-2.9%). Major perioperative complications included stroke (2.4% [1.8%-3.3%]), spinal cord ischemia (1.4% [1.0%-2.2%]), retrograde type A aortic dissection (1.2% [0.8%-1.8%]), type I endoleak (5.6% [3.6%-8.6%]), visceral ischemia (1.0% [0.5%-2.1%]), and acute renal failure (2.8% [2.0%-3.8%]). Mid-term mortality was 5.1% (3.6%-7.3%), and secondary intervention rate was 4.9% (4.0%-6.0%) with 1.7% (1.0%-2.9%) conversion rate to open surgery. In subgroup analysis based on uncomplicated TBAD, in-hospital and mid-term mortality was 0.5% (0.2%-1.5%) and 0.6% (0.2-1.7%), respectively. Compared with data from Western countries, mainland Chinese patients had a lower mortality.
Conclusions: In mainland China, the outcomes of endovascular treatment for TBAD are comparable to those of Western countries. The large number of patients undergoing TEVAR in mainland China and its good performance support the use of TEVAR in uncomplicated TBAD.
(Copyright © 2024. Published by Elsevier Inc.)
تواريخ الأحداث: Date Created: 20240320 Date Completed: 20240612 Latest Revision: 20240612
رمز التحديث: 20240613
DOI: 10.1016/j.avsg.2023.12.087
PMID: 38508445
قاعدة البيانات: MEDLINE
الوصف
تدمد:1615-5947
DOI:10.1016/j.avsg.2023.12.087